What is the treatment for heavy bleeding associated with Nexplanon (etonogestrel) insertion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Heavy Bleeding with Nexplanon Insertion

NSAIDs are the first-line treatment for heavy bleeding associated with Nexplanon (etonogestrel) implant, with mefenamic acid 500 mg three times daily for 5 days or celecoxib 200 mg daily for 5 days being the most effective options. 1

Initial Assessment

  • Rule out underlying gynecological problems that could cause prolonged bleeding, including pregnancy, sexually transmitted infections, and pathologic uterine conditions (e.g., polyps or fibroids) 1
  • Verify proper placement of the Nexplanon implant, as displacement can sometimes cause abnormal bleeding patterns 2
  • Recognize that irregular bleeding is common with Nexplanon use - approximately 18% of users experience prolonged bleeding and 7% experience frequent bleeding 1

Treatment Algorithm

First-Line Treatment:

  • NSAIDs for short-term treatment (5-7 days) during days of bleeding 2, 1
    • Mefenamic acid 500 mg three times daily for 5 days has shown significant cessation of bleeding within 7 days 1
    • Celecoxib 200 mg daily for 5 days has demonstrated similar effectiveness 1
    • Other NSAIDs like naproxen, ibuprofen, or diclofenac sodium may also be effective 2, 3

Second-Line Treatment (if NSAIDs ineffective and patient is medically eligible):

  • Low-dose combined oral contraceptives for 10-20 days 1, 2
    • This hormonal treatment can help stabilize the endometrium and reduce bleeding 2
    • Should only be used in women without contraindications to estrogen 2

If Bleeding Persists:

  • Reassess for underlying gynecological problems 2, 1
  • If no underlying problem is found and bleeding remains unacceptable to the patient, counsel on alternative contraceptive methods 2, 1
  • Consider removal of the Nexplanon implant if bleeding severely impacts quality of life 1

Important Clinical Considerations

  • Enhanced counseling about expected bleeding patterns with Nexplanon can improve continuation rates 1
  • Bleeding irregularities with Nexplanon are generally not harmful but can significantly impact quality of life 1
  • Tranexamic acid may be considered in some cases but should be used with caution due to potential thrombosis risk in patients with history or risk of thromboembolism 2, 4
  • NSAIDs work by reducing prostaglandin levels, which are elevated in women with excessive menstrual bleeding 5
  • The evidence for NSAIDs in treating implant-related bleeding is extrapolated from studies on heavy menstrual bleeding and IUD-related bleeding, where they have shown effectiveness 6, 3, 5

Common Pitfalls and Caveats

  • Avoid attributing all bleeding to the Nexplanon implant without first investigating other potential causes 4
  • Do not continue ineffective treatments for prolonged periods - if initial treatment with NSAIDs fails to improve bleeding after 1-2 cycles, consider alternative approaches 1
  • Remember that some women may need to try multiple treatment options before finding an effective solution 1
  • NSAIDs are less effective than tranexamic acid for heavy bleeding, but tranexamic acid has more safety concerns 5
  • Avoid aspirin for treatment of heavy bleeding, as it may actually increase blood loss in some women 2

References

Guideline

Management of Prolonged Bleeding with Contraceptive Use

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Bleeding Patterns and Management in IUD Users

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding.

The Cochrane database of systematic reviews, 2019

Research

Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding.

The Cochrane database of systematic reviews, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.